Display options
Share it on

J Clin Transl Endocrinol. 2014 Jul 24;1(4):121-132. doi: 10.1016/j.jcte.2014.06.002. eCollection 2014 Dec.

Comparison of plantar pressure in three types of insole given to patients with diabetes at risk of developing foot ulcers - A two-year, randomized trial.

Journal of clinical & translational endocrinology

Ulla Hellstrand Tang, Roland Zügner, Vera Lisovskaja, Jon Karlsson, Kerstin Hagberg, Roy Tranberg

Affiliations

  1. Department of Orthopaedics, Institute of Clinical Sciences, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  2. Department of Prosthetics and Orthotics, Sahlgrenska University Hospital, Gothenburg, Sweden.
  3. Department of Mathematical Science/Mathematical Statistics, Chalmers University of Technology and University of Gothenburg, Sweden.

PMID: 29159093 PMCID: PMC5685010 DOI: 10.1016/j.jcte.2014.06.002

Abstract

BACKGROUND: Special insoles and shoes designed to prevent foot ulcers caused by repetitive high pressures are recommended for patients with diabetes who have any of the following risk factors: neuropathy; peripheral vascular disease; foot deformities; previous ulcers; amputation; and skin pathologies. However, there is a need for increased knowledge regarding: a) differences in the peak pressure (PP) and pressure time integral (PTI) for different types of insoles; and b) the properties of the pressure distribution for insoles used over a period of several months. We present the results of a randomized trial to compare the plantar pressures of three commonly used insoles.

OBJECTIVES: The primary objective was to compare the PP and PTI between three types of insoles. The secondary objective was to explore the long-term pattern of peak plantar pressure distribution and variations in specific regions of interest (ROI). The tertiary objective was to investigate the impacts of insole adjustments, how much the insoles were used, and the levels of patient satisfaction.

METHODS: In a 2-year trial, 114 patients with type 1 (

RESULTS: A mixed model analysis estimated lower PP values in the heel regions for the 35 EVA and 55 EVA insoles (171 ± 13 and 161 ± 13 kPa, respectively) than for the prefabricated insoles (234 ± 10 kPa) (

CONCLUSIONS: Custom-made insoles used in combination with stable walking shoes gave lower pressures at the heel region. The variation makes it difficult to detect a systematic difference in plantar pressure for the 6 ROI, if such a difference indeed exists. The levels of satisfaction and usage for all the insoles tested were high. The insoles maintained their pressure redistribution properties over long periods, and few adjustments were needed.

Keywords: 35 EVA, 35 shore EVA insoles; 55 EVA, 55 shore EVA insoles; Clinical trial; Diabetes; EVA, ethylene vinyl acetate; Foot ulcer; Insoles; MTH1, metatarsal head 1; MTH2, metatarsal head 2; MTH4, metatarsal head 4; MTH5, metatarsal head 5; Offloading; PP, peak pressure; PTI, pressure time integral; Prevention; ROI, region of interest

References

  1. Diabet Med. 2012 Dec;29(12):1534-41 - PubMed
  2. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:54-9 - PubMed
  3. Clin Biomech (Bristol, Avon). 2004 Jul;19(6):629-38 - PubMed
  4. J Biomech. 2005 Sep;38(9):1918-25 - PubMed
  5. J Diabetes Complications. 2013 Jul-Aug;27(4):391-400 - PubMed
  6. Diabetes Care. 2005 Aug;28(8):1869-75 - PubMed
  7. Acta Orthop Scand. 1995 Apr;66(2):181-92 - PubMed
  8. J Diabetes Complications. 2011 Mar-Apr;25(2):97-106 - PubMed
  9. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:225-31 - PubMed
  10. Lancet. 2011 Jul 2;378(9785):31-40 - PubMed
  11. Arch Intern Med. 1998 Jan 26;158(2):157-62 - PubMed
  12. Diabet Med. 2002 May;19(5):377-84 - PubMed
  13. Diabetes Care. 2003 Apr;26(4):1069-73 - PubMed
  14. J Biomech. 1997 Mar;30(3):243-50 - PubMed
  15. Diabetes Care. 1999 Jul;22(7):1036-42 - PubMed
  16. Diabetes Care. 2013 Dec;36(12):4109-16 - PubMed
  17. Diabetes Care. 1998 Jul;21(7):1071-5 - PubMed
  18. Physiother Res Int. 2012 Mar;17(1):29-35 - PubMed
  19. Diabetes Care. 2013 Jun;36(6):1613-8 - PubMed
  20. Clin Infect Dis. 2004 Aug 1;39 Suppl 2:S132-9 - PubMed
  21. Diabetes Care. 1990 May;13(5):513-21 - PubMed
  22. J Am Podiatr Med Assoc. 2010 Nov-Dec;100(6):518-29 - PubMed
  23. Diabetes Metab Res Rev. 2000 Sep-Oct;16 Suppl 1:S75-83 - PubMed
  24. Diabetes Care. 2008 Aug;31(8):1679-85 - PubMed
  25. J Vasc Surg. 2010 Sep;52(3 Suppl):37S-43S - PubMed
  26. Diabetes Care. 2004 Feb;27(2):474-7 - PubMed
  27. Diabetes Care. 1999 Jun;22(6):965-72 - PubMed
  28. J Diabetes Complications. 2013 Nov-Dec;27(6):621-6 - PubMed
  29. J Diabet Complications. 1990 Jan-Mar;4(1):21-5 - PubMed
  30. J Foot Ankle Res. 2012 Dec 05;5(1):31 - PubMed
  31. Ergonomics. 2002 Jun 20;45(8):537-55 - PubMed
  32. Lancet. 2005 Nov 12;366(9498):1719-24 - PubMed
  33. Diabetes Care. 2008 May;31(5):839-44 - PubMed
  34. J Diabetes Complications. 2000 Sep-Oct;14(5):235-41 - PubMed
  35. Diabet Med. 2009 Nov;26(11):1141-6 - PubMed
  36. Arch Phys Med Rehabil. 2012 Nov;93(11):2075-9 - PubMed
  37. QJM. 2007 Feb;100(2):65-86 - PubMed
  38. J Diabetes Complications. 2011 Jan-Feb;25(1):52-62 - PubMed
  39. Diabetes Care. 1999 Jul;22(7):1029-35 - PubMed
  40. Ann Ist Super Sanita. 2012;48(3):259-71 - PubMed
  41. Diabet Med. 1994 Jan-Feb;11(1):114-6 - PubMed
  42. Gait Posture. 2010 May;32(1):141-4 - PubMed
  43. Clin Biomech (Bristol, Avon). 2007 Jan;22(1):81-7 - PubMed

Publication Types